Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brefel-Courbon

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Revue Neurologique|July 14, 2009
[Digestive disturbances in Parkinson disease]C Brefel-Courbon
Revue Neurologique|August 1, 2000
[ What drug strategies are advisable for patients with advanced-stage Parkinson's]C Brefel-Courbon
Revue Neurologique|October 6, 2020
Chronic pain in Parkinson's disease: Clinical and pathophysiological aspectsA Marques, C Brefel-Courbon
Therapie|October 17, 1998
[Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients]O Rascol, C Brefel-Courbon, O Blin
La Revue Du Praticien|May 15, 1997
[Parkinson "plus"]N Fabre, C Brefel-Courbon, O Rascol
Advances in Neurology|November 22, 2002
The management of patients with early Parkinson's diseaseOlivier Rascol, C Brefel-Courbon, P Payoux, et al.
Parkinsonism & Related Disorders|September 10, 2002
The management of patients with early Parkinson's diseaseO Rascol, P Payoux, J Ferreira, et al.
Advances in Neurology|July 20, 1999
Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patientsO Rascol, C Brefel-Courbon, S Descombes, et al.
Advances in Neurology|May 12, 2001
The pharmacologic treatment of gait ignition failureO Rascol, N Fabre, C Brefel-Courbon, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|March 6, 2007
Drug-induced myoclonus: a French pharmacovigilance database studyC Brefel-Courbon, V Gardette, F Ory, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Revue Neurologique|July 14, 2009
[Digestive disturbances in Parkinson disease]C Brefel-Courbon
Revue Neurologique|August 1, 2000
[ What drug strategies are advisable for patients with advanced-stage Parkinson's]C Brefel-Courbon
Revue Neurologique|October 6, 2020
Chronic pain in Parkinson's disease: Clinical and pathophysiological aspectsA Marques, C Brefel-Courbon
Therapie|October 17, 1998
[Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients]O Rascol, C Brefel-Courbon, O Blin
La Revue Du Praticien|May 15, 1997
[Parkinson "plus"]N Fabre, C Brefel-Courbon, O Rascol
Advances in Neurology|November 22, 2002
The management of patients with early Parkinson's diseaseOlivier Rascol, C Brefel-Courbon, P Payoux, et al.
Parkinsonism & Related Disorders|September 10, 2002
The management of patients with early Parkinson's diseaseO Rascol, P Payoux, J Ferreira, et al.
Advances in Neurology|July 20, 1999
Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patientsO Rascol, C Brefel-Courbon, S Descombes, et al.
Advances in Neurology|May 12, 2001
The pharmacologic treatment of gait ignition failureO Rascol, N Fabre, C Brefel-Courbon, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|March 6, 2007
Drug-induced myoclonus: a French pharmacovigilance database studyC Brefel-Courbon, V Gardette, F Ory, et al.
Pageof 5